QuinStreet (NASDAQ:QNST) & Nutex Health (NASDAQ:NUTX) Head to Head Analysis

Nutex Health (NASDAQ:NUTX) and QuinStreet (NASDAQ:QNST) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

Profitability

This table compares Nutex Health and QuinStreet’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutex Health	-14.09%	-51.27%	-9.89%
QuinStreet	-1.31%	-4.13%	-2.37%

Risk & Volatility

Nutex Health has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500. Comparatively, QuinStreet has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500.

Insider and Institutional Ownership

5.3% of Nutex Health shares are owned by institutional investors. Comparatively, 97.8% of QuinStreet shares are owned by institutional investors. 38.5% of Nutex Health shares are owned by insiders. Comparatively, 5.0% of QuinStreet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Nutex Health and QuinStreet”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutex Health	$292.00 million	0.83	-$45.79 million	($9.39)	-4.76
QuinStreet	$928.72 million	1.11	-$31.33 million	($0.22)	-83.23

QuinStreet has higher revenue and earnings than Nutex Health. QuinStreet is trading at a lower price-to-earnings ratio than Nutex Health, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and price targets for Nutex Health and QuinStreet, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutex Health	0	0	2	0	3.00
QuinStreet	0	1	4	0	2.80

Nutex Health presently has a consensus price target of $67.50, suggesting a potential upside of 51.14%. QuinStreet has a consensus price target of $29.80, suggesting a potential upside of 62.75%. Given QuinStreet’s higher possible upside, analysts plainly believe QuinStreet is more favorable than Nutex Health.

Summary

QuinStreet beats Nutex Health on 11 of the 14 factors compared between the two stocks.

About Nutex Health

Nutex Health Inc. operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment owns and owns and leases land and hospital building. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. It also provides operational and managerial services, including management, billing, collections, human resources and recruiting, legal, accounting, and marketing. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

About QuinStreet

QuinStreet, Inc., an online performance marketing company, provides customer acquisition services for its clients in the United States and internationally. The company offers online marketing services, such as qualified clicks, leads, calls, applications, and customers through its websites or third-party publishers. It serves financial and home services industries. The company was incorporated in 1999 and is headquartered in Foster City, California.